Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Barter, P.; Nicholls, S.; Kastelein, J.; Rye, K.

doi:10.1161/CIRCULATIONAHA.114.014025

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Date

2015

Authors

Barter, P.

Nicholls, S.

Kastelein, J.

Rye, K.

Type:

Journal article

Citation

Circulation, 2015; 132(5):423-432

Statement of Responsibility

Philip J. Barter, Stephen J. Nicholls, John J. P. Kastelein, Kerry-Anne Rye

DOI

10.1161/CIRCULATIONAHA.114.014025

Description

Originally published August 3, 2015. Includes Response to Barter et al. by G. Kees Hovingh, Kausik K. Ray, S. Matthijs Boekholdt on pg. 432

Rights

Published Version

https://doi.org/10.1161/circulationaha.114.014025

Persistent link to this record

http://hdl.handle.net/2440/102161

Full item page

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record